anmelden
BX Swiss TOP 30 CHF
1.481,37
PKT
-4,23
PKT
-0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 07.11.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 07.11.19 | Zurich Insurance Outperform | RBC Capital Markets | |
| 07.11.19 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 07.11.19 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 07.11.19 | Roche buy | UBS AG | |
| 06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.11.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 04.11.19 | Holcim overweight | Morgan Stanley | |
| 04.11.19 | UBS buy | Goldman Sachs Group Inc. | |
| 04.11.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 01.11.19 | Swiss Re Sell | UBS AG | |
| 01.11.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 01.11.19 | UBS buy | Kepler Cheuvreux | |
| 01.11.19 | Swiss Re kaufen | Credit Suisse Group | |
| 31.10.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 31.10.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 31.10.19 | Swiss Re overweight | Barclays Capital | |
| 31.10.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 31.10.19 | Novartis Hold | Deutsche Bank AG | |
| 31.10.19 | UBS buy | Deutsche Bank AG | |
| 31.10.19 | Swiss Re Sell | UBS AG | |
| 31.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 30.10.19 | Holcim buy | Goldman Sachs Group Inc. | |
| 30.10.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 30.10.19 | UBS buy | Goldman Sachs Group Inc. | |
| 30.10.19 | UBS Equal weight | Barclays Capital | |
| 30.10.19 | UBS Neutral | JP Morgan Chase & Co. | |
| 30.10.19 | UBS Equal weight | Barclays Capital | |
| 30.10.19 | UBS Equal-Weight | Morgan Stanley | |
| 30.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 30.10.19 | UBS buy | UBS AG | |
| 30.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 29.10.19 | Holcim Equal weight | Barclays Capital | |
| 29.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.10.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 26.10.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 25.10.19 | Novartis Underweight | Barclays Capital |